Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe clinical trials that led to Wegovy's UK licence combined semaglutide with a reduced-calorie diet and increased physical activity — not the medicine alone. What you eat on semaglutide shapes how well that combination performs, and how you feel along the way. Semaglutide slows gastric emptying and reduces appetite signals in the brain, which means the food choices that once felt straightforward can need a rethink. Eating too much in one sitting, choosing low-protein meals, or relying on ultra-processed foods can all work against the medicine rather than alongside it. This page draws on NHS guidance on semaglutide and the evidence behind its licence to help you understand what a practical food plan looks like — and why each element matters. Semaglutide (Wegovy) is a prescription-only medicine; a prescriber assesses whether it suits you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, randomised adults with obesity to semaglutide 2.4mg or placebo alongside structured lifestyle intervention, a 500 kcal deficit alongside behavioural support. Participants on semaglutide achieved an average weight reduction of around 15% over 68 weeks. The lifestyle component was built into the trial design deliberately: the medicine reduces appetite, but it does not direct those calories towards protein-rich, nutrient-dense sources rather than biscuits. That direction has to come from the food plan.
Gastric emptying slows noticeably on semaglutide. Food sits in the stomach longer, which reinforces the feeling of fullness but also means that a large meal (particularly one high in fat) can trigger nausea, reflux or vomiting that persists for hours. Many people find that what worked well before they started treatment stops working quickly after. The practical upshot: smaller plates, eaten slowly, tend to reduce GI discomfort considerably. Eating more than four or five times a day in small amounts is a common adjustment in the first few weeks, not a sign that something has gone wrong.
Carbonated drinks are worth singling out. The bloating and belching they cause is amplified when gastric emptying is slowed, even sparkling water can be uncomfortable in the early weeks. Swapping to still water, herbal teas or low-sugar cordial is a small change that makes a noticeable difference for many people on treatment.
When calorie intake drops substantially, the body needs a signal to preserve lean muscle rather than break it down for fuel. Dietary protein is that signal. On semaglutide, total daily intake often falls considerably, not through willpower, but because the appetite suppression is real and sometimes dramatic, particularly around dose increases. If protein gets crowded out by the small amount of food that does seem appealing, muscle loss becomes a genuine concern alongside fat loss.
Practical protein targets vary by body weight and activity level, your prescriber or a registered dietitian can give you a personal figure. As a general principle, leading each meal with a protein source (eggs, fish, chicken, Greek yoghurt, pulses, tofu) before carbohydrate helps ensure the most nutritionally important macronutrient gets eaten when appetite is at its limit. A useful overview of portion guidance sits alongside the semaglutide food list on this site.
Hydration sits alongside protein as an underappreciated priority. Semaglutide-related nausea and reduced appetite can quietly reduce fluid intake at the same time as GI symptoms increase fluid losses. Keeping water nearby and sipping consistently through the day (rather than drinking large amounts quickly) avoids the dehydration that can make side effects feel worse and occasionally requires clinical attention.
There is no formal prohibited food list for semaglutide, but the pattern of what causes problems is consistent enough to be practical. High-fat meals (a heavy takeaway, a full English, very creamy sauces) slow emptying on top of the slowdown already caused by the medicine. The result is prolonged nausea, reflux and sometimes vomiting that can last most of the day. Reducing fat load per meal rather than eliminating fat entirely is the sensible approach; fat is still a necessary macronutrient, and cutting it completely often means cutting protein-rich foods alongside it.
Refined carbohydrates eaten without protein or fibre can spike blood glucose quickly and then drop it, the resulting hunger signal can feel confusing when the medicine is also suppressing appetite through a different pathway. Swapping white bread, white rice and pastries for oats, wholegrain bread, lentils and vegetables does not need to be an all-or-nothing overhaul; even partial substitutions tend to improve how stable energy levels feel between meals. People looking for structured guidance often find a ready-made semaglutide meal plan a useful starting framework.
Alcohol deserves a mention. Many people on semaglutide notice they feel the effects of alcohol more acutely and find their tolerance has dropped. There is no absolute prohibition, but drinking on an already reduced-calorie day, when the stomach empties more slowly than usual, is a combination worth approaching with caution.
Mornings are often the hardest meal on semaglutide. Appetite suppression tends to be strongest in the hours after waking, and nausea (if it is present) is frequently worse before the first meal than after. Forcing a large breakfast typically makes this worse. Smaller, protein-led options eaten after any nausea has settled work better for most people: a couple of eggs, some Greek yoghurt with a handful of berries, or a protein-based smoothie sipped slowly. Specific ideas are laid out in detail on the breakfast guide for Wegovy.
One change many people notice within the first few weeks is a reduction in what clinicians call food noise, the persistent mental background chatter about food, cravings and the next meal. For people who have lived with that experience for years, its quietening can feel remarkable. The food plan matters during this period precisely because it is possible to under-eat badly: the absence of craving is not the same as the presence of adequate nutrition. Structured meals at roughly consistent times, even when appetite is minimal, help maintain the nutrient intake that keeps energy levels and mood stable.
Cost is a practical consideration for many people starting treatment. An honest overview of what private semaglutide treatment involves financially is on the Wegovy price comparison page, the short version is that legitimate prescriptions include clinical oversight, which matters for safe dose adjustment. The full picture of what Wegovy involves, from eligibility to the injection process, is also covered if you are still weighing up whether it is the right route. When you are ready to explore treatment with a clinician, you can speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not an automated system.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.